19 June 2013
Keywords: columbia, starts, mrp, eu, striant, sr, firm
Article | 05 July 2004
US firm Columbia Laboratories has initiated the European Union's MutualRecognition Procedure for its Striant SR, a testosterone replacement
therapy for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2004
12 July 2004
28 June 2004
© 2013 thepharmaletter.com